242 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 5 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
GPC3Glypican 3Cancer-related genes
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneStomach cancer: 4.83e-4
Tissue enriched
GRIN2AGlutamate ionotropic receptor NMDA type subunit 2ACancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
H3F3AH3 histone family member 3ACancer-related genes
Predicted intracellular proteins
NucleoplasmRenal cancer: 1.21e-6
Expressed in all
H3F3BH3 histone family member 3BCancer-related genes
Predicted intracellular proteins
NucleoplasmExpressed in all
HIF1AHypoxia inducible factor 1 alpha subunitCancer-related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Plasma membrane
Expressed in all
HIST1H3BHistone cluster 1 H3 family member bCancer-related genes
Predicted intracellular proteins
Tissue enriched
HNF1AHNF1 homeobox ACancer-related genes
Predicted intracellular proteins
NucleoplasmTissue enhanced
HRASHRas proto-oncogene, GTPaseCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Liver cancer: 2.32e-4
Expressed in all
IDH1Isocitrate dehydrogenase (NADP(+)) 1, cytosolicCancer-related genes
Citric acid cycle related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Nuclear bodies
Cytosol
Renal cancer: 2.45e-5
Liver cancer: 6.93e-5
Expressed in all
IDH2Isocitrate dehydrogenase (NADP(+)) 2, mitochondrialCancer-related genes
Citric acid cycle related proteins
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
MitochondriaCervical cancer: 5.15e-5
Expressed in all
IKBKBInhibitor of nuclear factor kappa B kinase subunit betaCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
CytosolUrothelial cancer: 1.46e-6
Mixed
IL7RInterleukin 7 receptorCancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Microtubule organizing center
Tissue enhanced
JAK1Janus kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Renal cancer: 2.67e-4
Colorectal cancer: 2.81e-4
Breast cancer: 9.63e-4
Expressed in all
JAK2Janus kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Focal adhesion sites
Mixed
JAK3Janus kinase 3Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Renal cancer: 2.89e-14
Cervical cancer: 6.42e-5
Tissue enhanced
KCNJ5Potassium voltage-gated channel subfamily J member 5Cancer-related genes
Disease related genes
Potential drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KDM5CLysine demethylase 5CCancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Liver cancer: 2.11e-4
Expressed in all
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneRenal cancer: 7.26e-4
Tissue enhanced
KEAP1Kelch like ECH associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Microtubule organizing center
Cytosol
Cervical cancer: 3.28e-4
Expressed in all
KITKIT proto-oncogene receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneRenal cancer: 5.63e-4
Tissue enhanced
KLF4Kruppel like factor 4Cancer-related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmRenal cancer: 3.93e-5
Expressed in all
KLF6Kruppel like factor 6Cancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleus
Nucleoli fibrillar center
Vesicles
Cytosol
Renal cancer: 2.28e-4
Expressed in all
KMT2DLysine methyltransferase 2DCancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted intracellular proteins
Nucleus
Plasma membrane
Cytosol
Expressed in all
KRASKRAS proto-oncogene, GTPaseCancer-related genes
Disease related genes
Predicted intracellular proteins
RAS pathway related proteins
Renal cancer: 2.75e-5
Pancreatic cancer: 3.59e-4
Expressed in all
LEF1Lymphoid enhancer binding factor 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmRenal cancer: 2.47e-6
Endometrial cancer: 1.37e-5
Tissue enhanced
LRP1BLDL receptor related protein 1BCancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
LZTR1Leucine zipper like transcription regulator 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Liver cancer: 5.15e-4
Expressed in all
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Glioma: 2.68e-4
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolStomach cancer: 5.43e-5
Cervical cancer: 3.72e-4
Head and neck cancer: 7.98e-4
Expressed in all
MAP2K4Mitogen-activated protein kinase kinase 4Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cell Junctions
Expressed in all
MAP3K1Mitogen-activated protein kinase kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
Potential drug targets
Predicted membrane proteins
CytosolMixed
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Liver cancer: 4.95e-4
Expressed in all
MAXMYC associated factor XCancer-related genes
Disease related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Golgi apparatus
Vesicles
Thyroid cancer: 2.12e-4
Renal cancer: 5.57e-4
Expressed in all
MED12Mediator complex subunit 12Cancer-related genes
Disease related genes
Predicted intracellular proteins
NucleoplasmExpressed in all
MEN1Menin 1Cancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Stomach cancer: 6.31e-5
Liver cancer: 1.08e-4
Expressed in all
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Pancreatic cancer: 1.21e-7
Head and neck cancer: 6.75e-4
Expressed in all
MLH1MutL homolog 1Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
NucleoplasmLiver cancer: 8.24e-5
Expressed in all
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Mixed
MSH2MutS homolog 2Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Vesicles
Liver cancer: 1.72e-9
Endometrial cancer: 4.44e-4
Pancreatic cancer: 4.63e-4
Expressed in all
MSH6MutS homolog 6Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Vesicles
Renal cancer: 1.06e-7
Endometrial cancer: 1.34e-4
Liver cancer: 7.86e-4
Expressed in all
MTORMechanistic target of rapamycinCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytosol
Renal cancer: 1.49e-5
Expressed in all
MUTYHMutY DNA glycosylaseCancer-related genes
Disease related genes
Predicted intracellular proteins
NucleusLiver cancer: 4.76e-8
Renal cancer: 7.25e-5
Mixed
MYD88Myeloid differentiation primary response 88Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Vesicles
Mitochondria
Cytosol
Breast cancer: 8.45e-4
Mixed
MYOD1Myogenic differentiation 1Cancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Nuclear bodies
Cytosol
Tissue enriched
NBNNibrinCancer-related genes
Disease related genes
Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Lung cancer: 5.46e-5
Pancreatic cancer: 4.20e-4
Expressed in all
NCOR1Nuclear receptor corepressor 1Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Cytosol
Renal cancer: 7.92e-5
Expressed in all
NCOR2Nuclear receptor corepressor 2Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmExpressed in all
NF1Neurofibromin 1Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
MitochondriaExpressed in all
NF2Neurofibromin 2Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleus
Plasma membrane
Cytosol
Renal cancer: 2.89e-5
Expressed in all
NFE2L2Nuclear factor, erythroid 2 like 2Cancer-related genes
Predicted intracellular proteins
Transcription factors
Nucleus
Plasma membrane
Cytosol
Renal cancer: 2.26e-4
Expressed in all
« prev | Page of 5 | next »